dbio NEWS
& MEDIA
  • Facebook - Black Circle
  • Twitter - Black Circle
  • YouTube - Black Circle

follow US

FOLLOW US

NEWS

RSS Feed
 

Distributed Bio CSO Jacob Glanville to present at Antibody Engineering 2016

At December's IBC Antibody Engineering Conference in San Diego a very young looking Jake (check the picture on the IBC website) will be presenting twice. Jake's presentations are usually standing room only so make sure you mark your calendars. On December 12th at 5:15pm Jake will be presenting in the "INSIGHTS FROM INTEGRATING IMMUNE REPERTOIRE DATA WITH OTHER, COMPLEX BIOLOGICAL DATA" stream. The title of his presentation is: Reading the Receptor Repertoire: Computational Prediction of Specificity from Primary Sequence Enables Rapid Antigen Discovery in Humans On December 13th at 1:45pm Jake will give a scientific briefing: Leveraging New Synthesis Technologies to Combine Molecular Fitness

Twist Bioscience and Distributed Bio Partner to Offer Antibody Design and Optimization Services

Distributed Bio and Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis on silicon, today announced a collaboration to offer therapeutic antibody design and optimization services, as well as an exclusive G-protein coupled receptor (GPCR) targeting library, for Twist Bioscience customers. The custom software, to be developed by Distributed Bio exclusively for Twist Bioscience, will enable pharmaceutical and biotechnology companies to easily use Twist Bioscience’s high-throughput long oligo synthesis technology to revolutionize how they design, engineer and optimize their antibody leads to identify high quality, fully-human antibody therape

PRESS

 

Distributed Bio in the news

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio's efforts to 

BUSINESS WIRE | Oct 25, 2018

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio Announces SuperHuman Platform Transfer to Kadmon

BUSINESS WIRE | Feb. 28, 2018

Pfizer, Boehringer sign JLABS resident Distributed Bio’s antibody discovery platform

FIERECE BIOTECH | Jan. 11, 2018

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

BUSINESS WIRE | Jan. 5 2018

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

BUSINESS WIRE | Dec. 12, 2017

Distributed Bio and Boehringer Ingelheim Announce SuperHuman Platform Transfer

BUSINESS WIRE | Dec. 11, 2017

VIDEOS

All videos are free to view & download

 

PUBLICATIONS

 

PRESENTATIONS

All presentations are free to view & download

 

SUPERHUMAN 2.0

CARTERRA

PROTEIN ENGINEERING

SUMMIT

IBC TALK 2017

PEGS 2012

THE BETTER BIOLOGIC

PEGS 2013

REPERTOIRE ANALYSIS

& BIOLOGICS OPTIMIZATIONS

NOVEL SEQUENCING TECHNIQUES & COMPUTATIONAL DISCOVERY

CHARACTERIZING HERITABLE VARIATION IN THE ANTIBODY REPERTOIRE

(415) 489-0246

201 Gateway Blvd, Floor 1

 South San Francisco, CA 94080, USA